Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1783/147118906775275073 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intelligent antibacterial coatings based on sensitive response and periodic fast drug release for long-term defense against corrosion induced by sulfate-reducing bacteria.
J Colloid Interface Sci
January 2025
Department of Materials Science and Engineering, Shaanxi Province Key Laboratory of Corrosion and Protection, Xi'an University of Technology, Xi'an 710048 PR China.
Pitting corrosion caused by sulfate-reducing bacteria (SRB) significantly shortens the lifespan of metallic pipelines. Antibacterial coatings containing S-responsive drug-loaded nanocontainers represent a promising method to mitigate SRB corrosion. However, the challenge of balancing rapid bactericide release with continuous antibacterial effect limits their practical application.
View Article and Find Full Text PDFPreconception counselling at long-acting reversible contraception (LARC) removals.
BMJ Sex Reprod Health
December 2024
Research Department of Reproductive Health, University College London (UCL) EGA Institute for Women's Health, London, UK.
National assessment on the frequency of pain medication prescribed for intrauterine device insertion procedures within the Veterans Affairs Health Care System.
PLoS One
January 2025
US Department of Veterans Affairs, Palo Alto Healthcare System, National Center for Collaborative Healthcare Innovation, Palo Alto, California, United States of America.
Background: The intrauterine device (IUD) is a highly effective form of long-acting reversible contraception, widely recognized for its convenience and efficacy. Despite its benefits, many patients report moderate to severe pain during and after their IUD insertion procedure. Furthermore, reports suggest significant variability in pain control medications, including no adequate pain medication.
View Article and Find Full Text PDFEffectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort.
Lancet HIV
January 2025
Stichting HIV Monitoring, Amsterdam, Netherlands; Department of Infectious Diseases, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, Netherlands.
Background: Real-world data showing the long-term effectiveness of long-acting injectable cabotegravir and rilpivirine are scarce. We assessed the effectiveness of cabotegravir and rilpivirine in all individuals who switched to cabotegravir and rilpivirine in the Netherlands.
Methods: We used data from the ATHENA cohort, an ongoing observational nationwide HIV cohort in the Netherlands.
Comparative cross-sectional study on the prevalence, determinants and willingness to use long-acting reversible contraception among female students attending public and private universities in Ekiti State, Southwest Nigeria.
BMJ Open
January 2025
Department of Law, Afe Babalola University, Ado-Ekiti, Nigeria.
Objectives: Long-acting reversible contraception (LARC) provides continuous pregnancy prevention to women for a period of 3 to 12 years, and it is very safe and effective. The aim of this study was to determine the prevalence, determinants and willingness to use LARC among undergraduate female students attending public and private universities in Ekiti State, Southwest Nigeria DESIGN: This survey employed a cross-sectional comparative study design.
Setting: Public and private universities in Ekiti State, Southwest Nigeria.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!